Commission launches consultation on responsible nano research

The European Commission has launched a consultation on responsible research in nanosciences and nanotechnologies.

The consultation is part of the Commission's plan to suggest that the EU Member States sign up to a Code of Conduct for this emerging area of science. A broad spectrum of society is addressed by the consultation, from the scientific community and industry to civil society, policy-makers, media and the general public.

"Nanosciences and nanotechnologies have the potential to drive growth and jobs in Europe, and their development and use should not be delayed, unbalanced or left to chance," said EU Science and Research Commissioner Janez Potocnik. "It is important that we pursue this knowledge with full understanding of the possible implications of these new areas of science, and that we do so openly and involving all concerned."

The Commissioner also stressed that the consultation demonstrates the Commission's commitment to 'developing the potential of nanosciences with appropriate safeguards'.

Estimates as to the market potential of nanotechnology products vary, but are all very positive. The Mitsubishi Institute estimated in 2002 that the market would be worth USD 150 billion (around €110 billion) by 2010, while in 2004 the Lux Research group predicted that the market would be worth USD 2.6 trillion (around €1.9 trillion) by 2014.

If this latter estimate is proved to be accurate, it will mean the nanoscience and nanotechnology market overtaking the information and communication technologies (ICT) market, and growing to 10 times the size of the biotechnology market.

However, concerns over safety have put the brakes on some research into the nanosciences and nanotechnologies. The principal concerns cover the ability of nanoparticles to cross natural bio-boundaries, and the prospect of connecting living creatures and human-made materials and systems.

These concerns have led to the development of a new area of research: the responsible management and control of nanosciences. This involves ethics, safety, the environment, individual rights, and the protection of personal data.

The Code of Conduct would encompass basic principles on which to base future developments in nano research, and would invite signatories to take concrete action to ensure that nanotechnologies are developed in a safe manner.

The consultation will close on 21 September.

For further information, please visit:
http://europa.eu/sinapse/directaccess/
science-and-society/public-debates/nano-recommendation/

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...